Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma
- PMID: 12062607
- DOI: 10.1016/s0360-3016(02)02760-8
Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma
Abstract
Purpose: To compare intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy (3D-CRT) for the boost treatment of new-onset nasopharyngeal carcinoma (NPC) or the salvage treatment of locally recurrent NPC.
Methods and materials: Between January 14 and February 23, 2000, 5-field 3D-CRT treatment plans were generated for 14 consecutive NPC patients using the ADAC Pinnacle planning system in Chang Gung Memorial Hospital, Kaohsiung, Taiwan. The planning data of these patients were later transferred to Memorial Sloan-Kettering Cancer Center, where new IMRT plans, also using 5-7 radiation fields were created for each patient using an inverse treatment planning system. The IMRT and 3D-CRT plans were compared for all 14 patients. The relationship between the anatomic shapes and locations of targets and the results of different plans were studied.
Results: Target doses were more homogeneous in IMRT plans. The average maximal brainstem dose (D(05), the dose received by 5% of the brainstem volume) decreased from 30.9% of the prescription dose with 3D-CRT to 15.3% and 14.7% with 5- and 7-field IMRT, respectively (p = 0.004 and 0.003, respectively, compared with 3D-CRT, paired Student's t test). Five anatomic factors were found that predicted greater benefits with IMRT. These factors were (1) vertical length of target >7 cm, (2) minimal distance between target and brainstem <0.1 cm, (3) maximal AP overlap of target and brainstem >0.6 cm, (4) maximal AP overlap of target and spinal cord >1 cm, and (5) vertical overlap of target and eyes >0 cm. For the 7 patients with at least 1 of these 5 anatomic factors, the benefits achieved by IMRT planning would have been greater than the benefits for the other 7 patients (p = 0.005, Fisher's exact test).
Conclusion: For boost or salvage treatment of NPC, lower normal tissue doses and more homogeneous target doses were achieved with IMRT plans. For NPC patients with at least 1 of the 5 anatomic factors, IMRT is highly recommended.
Similar articles
-
Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):145-57. doi: 10.1016/s0360-3016(03)00075-0. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694833
-
Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.Med Dosim. 2007 Winter;32(4):263-70. doi: 10.1016/j.meddos.2007.02.006. Med Dosim. 2007. PMID: 17980826
-
Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):481-8. doi: 10.1016/s0360-3016(03)00570-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957260
-
IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06).Strahlenther Onkol. 2016 Jun;192(6):377-85. doi: 10.1007/s00066-016-0959-y. Epub 2016 Mar 14. Strahlenther Onkol. 2016. PMID: 26972085 Review. English.
-
Clinical implementation of intensity-modulated radiation therapy.Med Dosim. 2002 Summer;27(2):161-9. doi: 10.1016/s0958-3947(02)00099-7. Med Dosim. 2002. PMID: 12074468 Review.
Cited by
-
Radiation-induced cranial neuropathy in patients with nasopharyngeal carcinoma. A follow-up study.Strahlenther Onkol. 2012 Mar;188(3):282-6. doi: 10.1007/s00066-011-0047-2. Strahlenther Onkol. 2012. PMID: 22314578
-
With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case-control study.BMC Cancer. 2016 Oct 7;16(1):774. doi: 10.1186/s12885-016-2803-2. BMC Cancer. 2016. PMID: 27717335 Free PMC article.
-
Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.Strahlenther Onkol. 2010 Mar;186(3):135-42. doi: 10.1007/s00066-010-2048-y. Epub 2010 Feb 22. Strahlenther Onkol. 2010. PMID: 20339827
-
Current management strategy of nasopharyngeal carcinoma.Clin Exp Otorhinolaryngol. 2010 Mar;3(1):1-12. doi: 10.3342/ceo.2010.3.1.1. Epub 2010 Mar 30. Clin Exp Otorhinolaryngol. 2010. PMID: 20379395 Free PMC article.
-
The challenge in treating locally recurrent T3-4 nasopharyngeal carcinoma: the survival benefit and severe late toxicities of re-irradiation with intensity-modulated radiotherapy.Oncotarget. 2017 Jun 27;8(26):43450-43457. doi: 10.18632/oncotarget.15896. Oncotarget. 2017. PMID: 28427216 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials